$0.535
0[0.00%]
Last update: 9:57AM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$1.21
0.6750[126.17%]
| Open- | Close- |
| Vol / Avg.0 / 4.248K | Mkt Cap64.104M |
| Day Range- - - | 52 Wk Range0.065 - 0.586 |
Yubo Intl Biotech Stock (OTC:YBGJ), Key Statistics
Yubo Intl Biotech Stock (OTC: YBGJ) analysis, key statistics.
Valuation Measures
Enterprise Value
64.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
272.17
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.01
Tangible Book value per share
-0.01
Total Liabilities (Quarterly)
3.1M
Total Assets
2M
Total Liabilities
3.1M
Profitability
Net income Growth
- -
Gross Margin
61.89%
Net Margin
-25687.2%
EBIT Margin
-25683.64%
EBITDA Margin
-24402.38%
Operating Margin
-25683.64%
Yubo Intl Biotech Stock (OTC:YBGJ), Key Statistics
Yubo Intl Biotech Stock (OTC: YBGJ) analysis, key statistics.
Valuation Measures
Enterprise Value
64.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
272.17
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.01
Tangible Book value per share
-0.01
Total Liabilities (Quarterly)
3.1M
Total Assets
2M
Total Liabilities
3.1M
Profitability
Net income Growth
- -
Gross Margin
61.89%
Net Margin
-25687.2%
EBIT Margin
-25683.64%
EBITDA Margin
-24402.38%
Operating Margin
-25683.64%
Yubo Intl Biotech Stock (OTC:YBGJ), Key Statistics
Yubo Intl Biotech Stock (OTC: YBGJ) analysis, key statistics.
Valuation Measures
Enterprise Value
64.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
272.17
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.01
Tangible Book value per share
-0.01
Total Liabilities (Quarterly)
3.1M
Total Assets
2M
Total Liabilities
3.1M
Profitability
Net income Growth
- -
Gross Margin
61.89%
Net Margin
-25687.2%
EBIT Margin
-25683.64%
EBITDA Margin
-24402.38%
Operating Margin
-25683.64%
Yubo Intl Biotech Stock (OTC:YBGJ), Key Statistics
Yubo Intl Biotech Stock (OTC: YBGJ) analysis, key statistics.
Valuation Measures
Enterprise Value
64.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
272.17
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.01
Tangible Book value per share
-0.01
Total Liabilities (Quarterly)
3.1M
Total Assets
2M
Total Liabilities
3.1M
Profitability
Net income Growth
- -
Gross Margin
61.89%
Net Margin
-25687.2%
EBIT Margin
-25683.64%
EBITDA Margin
-24402.38%
Operating Margin
-25683.64%
Yubo Intl Biotech Stock (OTC:YBGJ), Key Statistics
Yubo Intl Biotech Stock (OTC: YBGJ) analysis, key statistics.
Valuation Measures
Enterprise Value
64.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
272.17
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.01
Tangible Book value per share
-0.01
Total Liabilities (Quarterly)
3.1M
Total Assets
2M
Total Liabilities
3.1M
Profitability
Net income Growth
- -
Gross Margin
61.89%
Net Margin
-25687.2%
EBIT Margin
-25683.64%
EBITDA Margin
-24402.38%
Operating Margin
-25683.64%
Yubo Intl Biotech Stock (OTC:YBGJ), Key Statistics
Yubo Intl Biotech Stock (OTC: YBGJ) analysis, key statistics.
Valuation Measures
Enterprise Value
64.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
272.17
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.01
Tangible Book value per share
-0.01
Total Liabilities (Quarterly)
3.1M
Total Assets
2M
Total Liabilities
3.1M
Profitability
Net income Growth
- -
Gross Margin
61.89%
Net Margin
-25687.2%
EBIT Margin
-25683.64%
EBITDA Margin
-24402.38%
Operating Margin
-25683.64%
Yubo Intl Biotech Stock (OTC:YBGJ), Key Statistics
Yubo Intl Biotech Stock (OTC: YBGJ) analysis, key statistics.
Valuation Measures
Enterprise Value
64.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
272.17
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.01
Tangible Book value per share
-0.01
Total Liabilities (Quarterly)
3.1M
Total Assets
2M
Total Liabilities
3.1M
Profitability
Net income Growth
- -
Gross Margin
61.89%
Net Margin
-25687.2%
EBIT Margin
-25683.64%
EBITDA Margin
-24402.38%
Operating Margin
-25683.64%
Yubo Intl Biotech Stock (OTC:YBGJ), Key Statistics
Yubo Intl Biotech Stock (OTC: YBGJ) analysis, key statistics.
Valuation Measures
Enterprise Value
64.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
272.17
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.01
Tangible Book value per share
-0.01
Total Liabilities (Quarterly)
3.1M
Total Assets
2M
Total Liabilities
3.1M
Profitability
Net income Growth
- -
Gross Margin
61.89%
Net Margin
-25687.2%
EBIT Margin
-25683.64%
EBITDA Margin
-24402.38%
Operating Margin
-25683.64%
Yubo Intl Biotech Stock (OTC:YBGJ), Key Statistics
Yubo Intl Biotech Stock (OTC: YBGJ) analysis, key statistics.
Valuation Measures
Enterprise Value
64.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
272.17
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.01
Tangible Book value per share
-0.01
Total Liabilities (Quarterly)
3.1M
Total Assets
2M
Total Liabilities
3.1M
Profitability
Net income Growth
- -
Gross Margin
61.89%
Net Margin
-25687.2%
EBIT Margin
-25683.64%
EBITDA Margin
-24402.38%
Operating Margin
-25683.64%